The application of computer to volumetric analysis of drugs: the assay of weakly acidic water-soluble drugs
Luo, G.A.; Yu, R.G.
Yao Xue Xue Bao 20(2): 146-150
1985
ISSN/ISBN: 0513-4870 PMID: 4036621 Document Number: 251089
Document emailed within 1 workday
Related Documents
Ohsawa, I.; Tomino, Y. 2012: Renal excretion of water-soluble drugs Nihon Jinzo Gakkai Shi 54(7): 977-980Zhao, C.; Gao, W.; Sun, Y.; Si, S.; Xue, X. 1990: Determination of water soluble silicon from herbal drugs Zhongguo Zhong Yao Za Zhi 15(9): 555-556; 577
Wei, S.L.; Pu, X.Y. 1987: Application of the computer in predicting the stability of drugs Yao Xue Xue Bao 22(4): 289-293
Fu, X.C.; Wang, G.P.; Wang, Y.H.; Liang, W.Q. 2004: A predictive model for the release of slightly water-soluble drugs from HPMC matrices Die Pharmazie 59(8): 624-626
El Kheir, A.A.; Belal, S.; el Shanwani, A. 1985: Application of difference spectrophotometry to the nitrosation reaction in the assay of certain antipyretic drugs Die Pharmazie 40(1): 62
Jürgens, K.; Müller, B.W. 2005: A new formulation concept for drugs with poor water solubility for parenteral application Die Pharmazie 60(9): 665-670
Lambotte, L. 1970: Description of a computer surveillance system for isolated liver: application to the study of drugs protecting the liver from anoxic lesions Acta Chirurgica Belgica 69(9): 717-740
Beresewicz, M.; Bidzińska, E.; Koszewska, I.; Puzyński, S. 1991: Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs) Psychiatria Polska 25(3-4): 13-18
Sarnoff, E. 1974: Report on drugs, acidic and neutral nitrogenous organics Journal - Association of Official Analytical Chemists 57(2): 253-254
Masse, J.; Chauvet, A. 1983: Application of thermal analysis to the determination of the purity of chemical drugs. Chlorprothixene as an example Annales Pharmaceutiques Francaises 41(6): 579-589
Maresova, V.; Chadt, J.; Novakova, E. 2008: Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry Neuro Endocrinology Letters 29(5): 749-754
Hecht, S.S.; Carmella, S.; Mori, H.; Hoffmann, D. 1981: A study of tobacco carcinogenesis. XX. Role of catechol as a major cocarcinogen in the weakly acidic fraction of smoke condensate Journal of the National Cancer Institute 66(1): 163-169
Kojima, S.; Oba, T. 1971: Application of infrared absorption spectroscopy to examination of drugs and their preparations. XX. Studies on the polymorphism by differential thermal analysis and infrared analysis Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 89: 4-9
Bassiouny, M.A. 2013: Dental erosion due to abuse of illicit drugs and acidic carbonated beverages General Dentistry 61(2): 38-44
Rzeszutko, W.; Janik, B. 1973: Use of Cu-2+ as an indicator in assaying some drugs by means of volumetric titration. 8. Determination of chlorpromazine and imipramine hydrochlorides Acta Poloniae Pharmaceutica 30(3): 307-309
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Corti, P.; Murratzu, C.; Caricchia, A.; Corbini, G. 1987: Thin layer chromatography and densitometry for drugs assay. Note. IV. Assay of 1,4-benzodiazepine compound in the urine Bollettino Chimico Farmaceutico 126(9): 376-384
Liu, R.; Duan, J.-a.; Wu, H.; Liu, P.; Shang, E.-x.; Qian, D.-w. 2015: Analysis and identification of water soluble components of water buffalo horn Yao Xue Xue Bao 50(5): 594-598
Arambasić, M.B.; Pitić, L.J.; Jeremić, D.; Adnadjević, D. 2002: Possibilities of the application of regression analysis and analysis of variance. II. Assessment and comparison of acute toxicity: presentation and practical application of the interactive computer program "LD50-MORTALITY" Bollettino Chimico Farmaceutico 141(4): 290-298
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826